MBD2 and B-cell chronic lymphocytic leukemia: Among the analyzed methyltransferases and demethylases, expression of DNMT1 resulted significantly reduced in CLL cells compared with HD B cells (Fig. 6A), in accordance with the lower methylation levels within the CAT promoter showed by CLL versus HD B cells (Fig. 4C).